Form SP 15D2 - Special Financial Report [Rule 15d-2]:
SEC Accession No. 0001213900-25-059643
Filing Date
2025-06-30
Accepted
2025-06-30 16:05:45
Documents
82
Period of Report
2024-12-31
Effectiveness Date
2025-06-30

Document Format Files

Seq Description Document Type Size
1 SP 15D2 ea0246984-sp15d2_jyongbio.htm   iXBRL SP 15D2 643857
2 CERTIFICATION ea024698401ex12-1_jyongbio.htm EX-12.1 7003
3 CERTIFICATION ea024698401ex12-2_jyongbio.htm EX-12.2 7114
4 CERTIFICATION ea024698401ex13-1_jyongbio.htm EX-13.1 5420
10 GRAPHIC image_001.jpg GRAPHIC 22436
  Complete submission text file 0001213900-25-059643.txt   5073817

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mens-20241231.xsd EX-101.SCH 56757
6 XBRL CALCULATION FILE mens-20241231_cal.xml EX-101.CAL 44628
7 XBRL DEFINITION FILE mens-20241231_def.xml EX-101.DEF 258268
8 XBRL LABEL FILE mens-20241231_lab.xml EX-101.LAB 467219
9 XBRL PRESENTATION FILE mens-20241231_pre.xml EX-101.PRE 282123
85 EXTRACTED XBRL INSTANCE DOCUMENT ea0246984-sp15d2_jyongbio_htm.xml XML 592907
Mailing Address 23F-3, NO.95, SEC. 1, XINTAI 5TH RD. XIZHI DIST. NEW TAIPEI CITY F5 221
Business Address 23F-3, NO.95, SEC. 1, XINTAI 5TH RD. XIZHI DIST. NEW TAIPEI CITY F5 221 (8862) 27325205
Jyong Biotech Ltd. (Filer) CIK: 0001954488 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: SP 15D2 | Act: 34 | File No.: 001-42701 | Film No.: 251092023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)